FDAsafety guidance83% confidence
Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to Merck.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Oncology · Immunotherapy
- Sub-indication
- General
Related signal: Merck's MK-1045 Under Investigation for Non-Hodgkin Lymphoma Treatment